Vertex Pharmaceuticals Total Long-Term Assets 2010-2024 | VRTX

Vertex Pharmaceuticals total long-term assets for the quarter ending September 30, 2024 were $12.436B, a 76.89% increase year-over-year.

  • Vertex Pharmaceuticals total long-term assets for 2023 were $8.586B, a 74.65% increase from 2022.
  • Vertex Pharmaceuticals total long-term assets for 2022 were $4.916B, a 26.97% increase from 2021.
  • Vertex Pharmaceuticals total long-term assets for 2021 were $3.872B, a 7.01% increase from 2020.

Vertex Pharmaceuticals Total Long-Term Assets 2010-2024 | VRTX

  • Vertex Pharmaceuticals total long-term assets for 2023 were $8.586B, a 74.65% increase from 2022.
  • Vertex Pharmaceuticals total long-term assets for 2022 were $4.916B, a 26.97% increase from 2021.
  • Vertex Pharmaceuticals total long-term assets for 2021 were $3.872B, a 7.01% increase from 2020.